PROOF-HD: About PROOF-HD (Ongoing)
The Huntington Study Group is conducting PROOF-HD, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of pridopidine in patients with early stage of Huntington disease. To learn more, visit www.PROOF-HD.org.
Видео PROOF-HD: About PROOF-HD (Ongoing) канала Huntington Study Group
Видео PROOF-HD: About PROOF-HD (Ongoing) канала Huntington Study Group
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
TREATING UNAWARENESS IN HDResearch Blitz: Neurocrine, Prilenia, uniQure, Wave, Novartis, Sage, and HDClarityI am the DIFFERENCETypes of Clinical Trials and Where to Find Them (Part 3)I AM THE DIFFERENCEHuntington disease is treatableHSG founder talks about treatments beyond medicationsPride-HD OverviewFAMILY PLANNING IN HDDemystifying Behavior in Huntington Disease - Katherine McDonellHuntington Disease: A Complementary & Integrative Approach - Danny BegaCME4HD now available online!Crest-E Trial for HDDNA Repair in Huntington’s Disease - Lesley JonesHSG 2022 Staff VideoMeet Jim GusellaLaVonne Goodman talks about HSGHD Innovators Forum with Live Q&A Panel - Neubase, NeuExcell, Ophidian, PTC, and TripletHSG Working Group Presentations - Nora Fritz, Lori Quinn, and Jamie AdamsAbout PROOF-HD (Full Length)Myths/Barriers/Risks to Participating in a Clinical Trial (Part 2)